These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of Diabetic Charcot Patients With and Without Foot Wounds. Wukich DK; Sadoskas D; Vaudreuil NJ; Fourman M Foot Ankle Int; 2017 Feb; 38(2):140-148. PubMed ID: 27923212 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective. Su HY; Yang CY; Ou HT; Chen SG; Chen JC; Ho HJ; Kuo S JAMA Netw Open; 2023 Jan; 6(1):e2250639. PubMed ID: 36633847 [TBL] [Abstract][Full Text] [Related]
8. [Surgical treatment of the Charcot foot : long-term results and systematic review]. Hartig N; Krenn S; Trnka HJ Orthopade; 2015 Jan; 44(1):14-24. PubMed ID: 25586504 [TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842 [TBL] [Abstract][Full Text] [Related]
10. Deformity and Clinical Outcomes Following Operative Correction of Charcot Foot: A New Classification With Implications for Treatment. Pinzur MS; Schiff AP Foot Ankle Int; 2018 Mar; 39(3):265-270. PubMed ID: 29172758 [TBL] [Abstract][Full Text] [Related]
11. Risk Factors Associated With Major Lower Extremity Amputation After Osseous Diabetic Charcot Reconstruction. Elmarsafi T; Anghel EL; Sinkin J; Cooper PS; Steinberg JS; Evans KK; Kim PJ; Attinger CE J Foot Ankle Surg; 2019 Mar; 58(2):295-300. PubMed ID: 30850098 [TBL] [Abstract][Full Text] [Related]
12. Reverse Total Shoulder Arthroplasty Is the Most Cost-effective Treatment Strategy for Proximal Humerus Fractures in Older Adults: A Cost-utility Analysis. Abdel Khalik H; Humphries B; Zoratti M; Axelrod D; Kruse C; Ristevski B; Rajaratnam K; Gardner M; Tarride JÉ; Johal H Clin Orthop Relat Res; 2022 Oct; 480(10):2013-2026. PubMed ID: 35507306 [TBL] [Abstract][Full Text] [Related]
13. Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2021; 21(7):1-165. PubMed ID: 34211616 [TBL] [Abstract][Full Text] [Related]
14. Cost comparison: limb salvage versus amputation in diabetic patients with charcot foot. Gil J; Schiff AP; Pinzur MS Foot Ankle Int; 2013 Aug; 34(8):1097-9. PubMed ID: 23493775 [TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes and Complications of Midfoot Charcot Reconstruction With Intramedullary Beaming. Ford SE; Cohen BE; Davis WH; Jones CP Foot Ankle Int; 2019 Jan; 40(1):18-23. PubMed ID: 30284492 [TBL] [Abstract][Full Text] [Related]
16. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487 [TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer. Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous surgical repair of a tibialis anterior tendon rupture and diabetic charcot neuroarthropathy of the midfoot: a case report. Stapleton JJ Clin Podiatr Med Surg; 2013 Oct; 30(4):599-604. PubMed ID: 24075138 [TBL] [Abstract][Full Text] [Related]